Document Detail


Clinical spectrum of acute sporadic hepatitis E and possible benefit of glycyrrhizin therapy.
MedLine Citation:
PMID:  12084556     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of the present study was to record the spectrum of sporadic hepatitis due to hepatitis E virus infection with special reference to moderate and severe liver disease, described as sub-acute hepatitis. Further, efficacy of glycyrrhizin therapy was studied as an open trial. Sixty-two consecutive patients were registered for the study. The clinical and laboratory profile of the patients was recorded on a preplanned proforma. Moderate and severe hepatitis was arbitrarily defined on the basis of clinical symptoms and serum bilirubin (total) of 10-15 mg% and 16 mg% or higher, respectively, at the time of presentation. It was noted that 22 (36.1%) of acute sporadic hepatitis E patients had moderate or severe liver disease. Glycyrrhizin was administered to these 22 patients by intravenous (IV) route in the dose of 60 ml daily. Therapy was tapered and stopped once significant clinical and biochemical improvement was noted. All patients showed clinical improvement by the seventh day of therapy. Total bilirubin was reduced by 68.9% by the end of 2 weeks of treatment and at this time, reduction in AST and ALT levels was to the tune of 94 and 97%, respectively. Normalization of AST and ALT levels was recorded in 19 patients (86.4%) and total bilirubin in 13 (59.1%) patients within 30 days of commencement of therapy. There were no side effects of IV glycyrrhizin therapy. It is concluded from the results of the present study that over one-third patients with acute sporadic hepatitis E in India have either moderate or severe liver injury. IV glycerrhizin therapy in this group of patients is well tolerated and effective.
Authors:
Anurag Tandon; B N. Tandon; R A. Bhujwala
Related Documents :
19491836 - Histological disease in asian-americans with chronic hepatitis b, high hepatitis b viru...
13679326 - Hepatic injury in 12 patients taking the herbal weight loss aids chaso or onshido.
20807336 - Prevalence, risk factors and causes of discordance in fibrosis staging by transient ela...
16487446 - Associations between liver histology and cortisol secretion in subjects with nonalcohol...
18432536 - Rising from a chair: a simple screening test for physical function in predialysis patie...
7814206 - Antichlamydial activity of lacrimal fluid in patients with trachoma.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Hepatology research : the official journal of the Japan Society of Hepatology     Volume:  23     ISSN:  -     ISO Abbreviation:  Hepatol. Res.     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-Jun-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9711801     Medline TA:  Hepatol Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  55-61     Citation Subset:  -    
Affiliation:
Pushpawati Singhania Research Institute, Digestive Diseases Foundation, DDA SFS Flats, 3 C Vijay Mandal Enclave, 110 016, New Delhi, India
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers.
Next Document:  Transient biochemical response in interferon therapy decreases the development of hepatocellular car...